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Noncompaction cardiomyopathy (NCCM) is a primary, genetic cardiomyopathy with variable clinical manifestations
that include mitral regurgitation (MR).
Methods: This study comprised patients diagnosed with NCCM and MR in two cardiac centers (King Abdul-Aziz
Cardiac Center, Riyadh, Kingdom of Saudi Arabia and Sudan Heart Institute, Khartoum, Sudan), and seen in the
period between 2002 and 2013. The study describes follow up, clinical, echocardiographic, and histopathological
findings.
Results: Nineteen cases (85% females) were identified. Ten percent of the cases had relapses and remissions of
heart failure. Echocardiographic features included leaflet retraction in all patients, characteristic malcoaptation,
and a zigzag deformity of anterior leaflet in 57% of patients. Ruptured chordae were found in 15% of the patients.
One patient had pathological examination of the mitral valve which showed myxomatous degeneration, and scle-
rotic and calcific changes.
Conclusion: We describe and discuss a new mechanism for MR caused by NCCM with identifiable clinical and
echocardiographic features, and pathological correlations.
 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
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Noncompaction cardiomyopathy (NCCM) isdescribed as excessive myocardial trabecu-
lation and deep inter-trabecular recesses, andhas recently been designated as a primary genetic
cardiomyopathy [1,2]. The disease is increasingly
being recognized, and reports suggest that the
condition is not rare but under-diagnosed [3].
Abbreviations
EF ejection fraction
MR mitral regurgitation
NCCM noncompaction cardiomyopathy
MV mitral valve
AML anterior mitral leaflet
PML posterior mitral leaflet
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2015;27:71–78NCCM, associated with mitral regurgitation
(MR) in the presence of preserved left ventricle
function, was observed in 2004 [4]. Subsequently,
other reports have confirmed this unique associa-
tion [5,6].
This study describes the mechanism of MR
associated with NCCM as a distinct entity with
recognizable clinical, echocardiographic and his-
topathologic characteristics, and emphasizes the
need to increase awareness of its distinctive
features.Methodology
This study focused on patients seen by the
authors in the period between 2002 and 2013.
The patients had been diagnosed with NCCM
and MR in two different cardiac centers (the King
Abdul-Aziz Cardiac Center, Riyadh, Kingdom of
Saudi Arabia and the Sudan Heart Institute,
Khartoum, Sudan) and followed up prospec-
tively. Clinical and echocardiographic examina-
tions were performed at presentation and on
follow up using standard methods. Echocardiog-
raphy was performed using Hewlett Packard
HP 5000 at King Abdul-Aziz Cardiac Center,
and Esaote My Lab 50 at the Sudan Heart Center.
Histopathological examination was done where
feasible.
Ethical clearance and permission to publish
patient information was obtained from the respec-
tive hospitals. The authors did not receive any
funding for this study.
Inclusion criteria
The study included patients whose NCCM was
diagnosed by echocardiographic criteria (see
below); patients whose ejection fraction (EF) was
>45% at the time of diagnosis or on follow up;
where mild or more MR associated with morpho-
logical changes in the mitral valve (MV) appara-
tus; and where there was an absence of a solid
alternative cause for MR.
Exclusion criteria
The study excluded patients with NCCM and
ejection fraction (EF) less than 45% or with
another solid cause for MR.
Diagnosis of NCCM
The diagnosis of NCCM was based on the crite-
ria outlined by Jenni et al. [7] However, we opted
to include those with associated congenital heart
disease. Diagnostic criteria included:1. In the parasternal short axis, the ventricular
myocardium has a two-layer appearance
(compacted and noncompacted).
2. Noncompacted to compacted layer thickness
ratio equals or is more than 2:1, measured at
the short axis view at the end of systole distal
to papillary muscles.
3. Inter-trabecular recesses were demonstrated
by using low scale color flow mapping.
Diagnosis of mitral regurgitation
The mitral valve morphology was examined by
2-D echocardiography. MR was assessed by Color
Flow Doppler. A 3–5 mm jet is considered mild,
5–7 mm with left atrial and ventricle dilatation is
considered moderate. A jet with vena contracta
of >7 mm with left atrial and ventricle dilatation
or with swirling jet or reversal of flow in pulmon-
ary veins is considered severe MR.Results
Nineteen patients were diagnosed with NCCM
and MR (four patients from King Abdul-aziz
Cardiac Center and 15 patients from the Sudan
Heart Center). MV histopathology was done for
one patient (Table 3 with other cases from the
literature).
Patient ages ranged between five months to
16 years with a mean of 5.7 years, and 85% of the
patients were females.
Clinical findings (Table 1)
Improvement of heart failure symptoms associ-
ated with improvement of ejection fraction was
found in two patients (10%).
Echocardiographic findings (Table 2)
Leaflet retraction was seen in all patients.
Abnormal coaptation of the anterior MV leaflet
(AML) superior to the posterior (PML) with a
zigzag deformity of AML (Fig. 1A and B) were
seen in 11 patients (57%). Chordal rupture was
observed in two patients (Fig. 2) and chordal
elongation in one patient (number 19, Fig. 5).
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Table 1. Clinical and echocardiographic features and the outcome of patients with VNC/MR.
No. Age/sex Reported by Clinical Echo Outcome
1 18 month/M Sulafa et al. [6] Heart failure Moderate MR Restriction of
leaflet motion zigzag
deformity and superior
coaptation of AML EF 65%
Lost to follow up
2 12 month/F
(Twin 1)
Sulafa et al. [6] Progressive Heart
failure
Severe MR Restriction of
leaflet motion Thickened MV
chordate Superior coaptation
of AML EF 65%
MV replacement Follow up at
10 years of age showed mitral
stenosis, EF 65%
3 12 month/F
(Twin 2)
Sulafa et al. [6] Severe Heart failure
at age of 7 days
which improved
completely at age
6 months
Initial echo at 7 days: dilated
LV, EF 20%, mild MR,
restriction of leaflet motion,
superior coaptation of AML.
Echo at 12 months: EF 70%,
mild MR and left ventricle
hypertrophy
Followed up till 10 years of age,
mild MR, EF 70%
4 5 month/F Sulafa et al.[6] Heart failure Large mid muscular VSD MV:
Restriction of leaflet motion,
Superior coaptation and
zigzag deformity of AML
Mild-moderate MR, EF 60%
VSD closure, sudden onset of
ventricular fibrillation on first
post operative day. Discharged
with hypoxic ischemic
encephalopathy. Lost to follow
up
5 18 month/F Sulafa Ali [10] Heart failure AML coapts superior to the
posterior leaflet with zigzag
deformity. Severe MR.
Ejection fraction is 62%
Follow up for 12 months, still
with severe MR
6 12 year/F Sulafa Ali [10] Heart failure AML coapts superior to the
posterior leaflet with zigzag
deformity. Moderate MR.
Ejection fraction is 65%
Follow up for 6 months, still with
severe MR
7 8 year/F Sulafa Ali [10] Heart failure Hypertrophic and
noncompaction
cardiomyopathy. Ejection
fraction is 80%. AML coapts
superior to the posterior
leaflet with moderate MR
No follow up
8 3 year/F Sulafa Ali [11] Heart failure AML coapts superior to the
posterior leaflet with zigzag
deformity. Severe MR.
Ejection fraction is 60%
Follow up 3/12, still with severe
MR
9 5 year/F Sulafa Ali [11] Heart failure AML coapts superior to the
posterior leaflet with zigzag
deformity. Severe MR.
Ejection fraction is 62%
No follow up
10 7 year/F Sulafa Ali [11] Heart failure AML coapts superior to the
posterior leaflet with zigzag
deformity. Severe MR.
Ejection fraction is 65%
No follow up
11 12 month/F New patient (by
the authors)
Heart failure Large VSD, AML coapts
superior to the posterior
leaflet with zigzag deformity
(Fig. 1 A). Moderate MR
Ejection fraction is 65%
Surgical VSD closure, Still with
moderate MR and normal EF at
8 months follow up
12 4 year/F New(by the
authors)
Heart failure EF 70%, Severe MR, ruptured
chordate (Fig. 2)
–
13 15 year/F New(by the
authors)
Heart failure EF 55%, Severe MR, zigzag
deformity of AML (Fig. 1B),
retracted MV leaflets with
extensive papillary muscle
involvement (Fig. 3A) central
MR jet (Fig. 3B)
–
(continued on next page)
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Table 3. Pathological correlation in patients with VNC-MR association.
Patient
No.
Author Description
1 Ali et al. [4] Sclerotic and calcific changes
2 Chung et al.
[5]
On gross findings of the left ventricle cavity, the anterior mitral leaflet chordae were ruptured and
severe noncompacted endomyocardium was observed. Owing to a friable posterior lateral papillary
muscle, Myxomatous degeneration and hemorrhage. (Fig. 4)
3 Igarashi
et al. [9]
Myxomatous degeneration of the ruptured chordai, mild fibrosis of papillary muscles
4 Curcic et al.
[11]
Myocardial tissue represents the basis of a huge left ventricle papillary muscle. Endocardial
fibroelastosis, dilated type. Hypocellular fibrous tissue with multiple lamellae of coarse elastic fibres
arranged parallel to the luminal surface. The endocardium is extremely thickened extending in the
subendocardium
Table 2. Echocardiographic features of VNC/MR association.
Feature No./Reported cases (%)
Leaflet retraction 19/19 (100)
Anterior leaflet coapts superior to the posterior leaflet (Fig. 1A) 11/19 (57)
Ruptured/elongated chordae 3/19 (15)
In the 4 chamber view the anterior leaflet has a zigzag deformity (Fig. 1A
and B)
11/19 (57)
A central MR jet (Fig. 3B) 16/19 (84)
Recovery of myocardial dysfunction 2/19 (10)
Associated congenital heart disease 2/19 (10) :Both with ventricular septal defect
(Fig. 1A)
Abbreviations: VNC, ventricular noncompaction; MV, mitral valve; MR, mitral regurgitation.
Table 1 (continued)
No. Age/sex Reported by Clinical Echo Outcome
14 4 year/M By the author Heart failure EF 60%, severe MR, retracted
leaflets, extensive papillary
muscle involvement central
MR jet
MV Replacement well 3 y after
surgery
15 5 year/F New (by the
authors)
A symptomatic,
referred because
heart murmur
EF 45%, Mild MR, retracted
leaflets
–
16 7 year/F New (by the
author)
Heart failure,
resolved with
treatment.
EF 47%, mild MR, retracted
leaflets
–
17 16 year/F New (by the
author)
Heart failure EF 65%, moderate MR,
ruptured chordate
18 2 year/M New Heart failure.
dysmorphic with
small head, squint
and delayed
development
EF 56%, Severe MR and TR.
Biventricular noncompaction,
tricuspid valve deformity.
(Fig. 4)
19 16 year/F New Heart failure Low EF 30%, Moderate MR,
Elongated chordate(Fig. 5)
EF improved over 4 months to
60%, moderate MR
Abbreviations: MR, mitral regurgitation; AML, anterior mitral leaflet; EF, ejection fraction; MV, mitral valve; VSD, ventricular septal defect; VNC,
ventricular noncompaction; TR, tricuspid regurgitation; LV, left ventricle.
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impaired (45–55%) in 20%. Improvement of EF
was associated with left ventricle (LV) hypertro-
phy in two patients.Pathological correlations
A pathological study was available for one of our
patients (number1), which revealed sclerotic and
calcific changes. The pathological features of this
Figure 1. (a) Four-chamber view of patient 11 showing a large VSD,
NCCM, and zigzag deformity of AML. (b) Four-chamber with aorta
view of patient 13 showing zigzag deformity of AML (black line).
Figure 2. Four-chamber view of patient 12 showing flail anterior MV
leaflet due to ruptured chordae.
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NONCOMPACTION CARDIOMYOPATHYpatient and three more patients from the litera-
ture are shown in Table 3.
Follow up
Eight patients were followed up for a period of
three to 120 months (mean of 36 months). Two
had mitral valve replacement with good outcome
at three and 10 years of age. In two patients, MR
continued to be severe after three to eight months
of follow up.Discussion
Improvement of heart failure symptoms associ-
ated with improvement of ejection fraction is oneof the distinctive clinical features of NCCM. Simi-
lar observations has been reported in patients
without MR [3]. Clinical relapses and remissions
distinguish NCCM from all other cardiomyopa-
thies where relapses are not known events. Simi-
lar observations were reported by Bhat et al. [8]
and Igarashi et al. [9] after MV surgery where ejec-
tion fraction significantly improved, a feature
rarely occurs in other forms of cardiomyopathy.
Another report by Martinez et al. [10] described
mild MR with low EF where, on follow up, EF
improved while MR worsened, emphasizing that
MR is not secondary to myocardial dysfunction.
Echocardiographic findings of abnormal
coaptation of the leaflets can be misinterpreted
as MV prolapse. This misinterpretation is clear
in the report by Martinez, where authors describe
the MV in a patient as ‘query prolapsed’, while the
PML had restricted movement (see Potential pit-
falls in diagnosis of NCCM-MR association
below). Chordal rupture, which was observed in
two patients, is an important finding and one that
has also been reported by others [5,9]. In addition,
we observed chordal elongation which may be the
precursor of rupture, and which can be explained
by an extensive papillary muscle involvement
noted by echocardiography (as in Figs. 3A and 4).
A distinct feature of NCCM-MR association is
preservation of myocardial systolic function. This
feature helps to differentiate this entity from MR
secondary to left ventricle (LV) systolic dysfunc-
tion. Recovery of myocardial dysfunction can be
associated with improvement of LV dilatation,
often with the thickening/hypertrophy of the left
ventricle myocardium (so-called undulating
phenotype) as in patient numbers 3 and 7.
Figure 3. (a) Four-chamber view of patient 13 showing retracted MV
leaflets, VNC with extensive papillary muscle involvement. (b) Four-
chamber view of patient 13 showing a large central MR jet, swirling
in left atrium.
Figure 5. Four-chamber with aorta view of patient 19 showing
elongated mitral valve chord (arrows).
Figure 4. Four-chamber view of patient 18 showing biventricular
noncompaction with mitral and tricuspid valve retraction and
deformity (arrows).
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be present [3].Intra operative and pathological correlations
Pathological features of NCCM-MR are avail-
able from one of our patients and three other
patients from the literature (Table 3). Sclerotic
and calcific changes were seen in our patient (4),
Myxomatous degeneration was found in two
patients. Papillary muscles were found to be
friable and fibrosed, and chordal rupture of
AML was documented during intra operativeexamination of the valve [5,9]. Endocardial
fibroelastosis was noted at the base of the papil-
lary muscle [11]. In addition, postmortem studies
performed for 14 cases of NCCM revealed two
patients with atrioventricular valve dysplasia
including one MV and one tricuspid valve,
findings that support our echocardiographic
observations. Furthermore, the authors of this
study described right ventricle involvement in 6/
14 patients, similar to our findings in patient
number 18 [12].
These pathological findings explain the echocar-
diographic features of malcoaptation which seems
to be secondary to chordal elongation/rupture due
to papillary muscle involvement.
Potential pitfalls in diagnosis of NCCM-MR
association
NCCM is typically an under-diagnosed condi-
tion due to the lack of full understanding of its
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NONCOMPACTION CARDIOMYOPATHYdistinctive features on the part of both cardiolo-
gists and echocardiographers. On the other hand,
the absence of consensus regarding its echocar-
diographic criteria may lead to over diagnosis.
The following may need to be observed for the
diagnosis of NCCM-MR association:
1. Criteria for NCCM: Several proposed criteria are
present but the most widely used is that of
Jenni et al. [7] Although these criteria need to
exclude associated heart disease, we omitted
this from our inclusion criteria as NCCM is
known to occur in patients with congenital
heart disease [3]. Some authors have expressed
concern about the reliability and reproducibil-
ity of these criteria especially since they depend
on loading conditions of the ventricle which is
the case in patients with MR [13]. Some authors
have used the term ‘hypertrabeculation,’ which
is synonymous with NCCM [13]. However, we
feel this leads to confusion and we suggest that
a unified nomenclature be used.
2. Exclusion of other causes of MR: In infants and
young children, congenital MR needs to be
carefully excluded in patients with NCCM-MR
association. The pattern of echocardiographic
abnormalities of the MV in NCCM-MR associa-
tion, though individually not pathognomonic,
renders the constellation of findings together
with the presence of NCCM a unique one. Fur-
thermore, in patients with congenital MR the
LV is usually dilated and thin walled rather
than hypertrabeculated.
In older children, acquired causes of MR like
rheumatic heart disease and MV prolapse should
be investigated. The typical pattern of rheumatic
MR constitutes tethering of the posterior leaflet
and malcoaptation of AML with eccentric posteri-
orly directed MR jet, features not present in
NCCM-MR association [14].
Features that help to distinguish NCCM-MR
association from MV prolapse
These include:
i. In MV prolapse, the leaflets have increased
mobility which usually involves both leaflets,
while in NCCM-MR association, leaflets have
retracted appearance with limited motion.
ii. The MR jet is usually eccentric, posteriorly
directed in MV prolapse, while it is usually
central in NCCM-MR association.
iii. The tips of the leaflets are typically thickened
in MV prolapse but not in NCCM-MR
association.Of note is that superior displacement of AML
and chordal rupture can occur in both MV pro-
lapse and NCCM-MR association.
Therapeutic and prognostic implications
of diagnosis of NCCM-MR association
In this patient cohort group, two patients under-
went MV replacement with good short and long
term outcomes. Tariq and Chung reported two
cases where the papillary muscle affection prohib-
ited MV repair, and the patients underwent MV
replacement with good short term outcome and
recovery of left ventricle systolic dysfunction
[5,8]. In two patients, ventricular septal defect clo-
sure was done, with one patient developing post
operative ventricular arrhythmia, a known com-
plication of NCCM, that led to neurological seque-
lae. The following are important implications of
the diagnosis on patient management:
1. Myocardial systolic dysfunction is a known
association of NCCM that needs to be consid-
ered at the time of surgery for MR and on
patient counseling. On the other hand, recovery
of myocardial function may be anticipated
before or after surgery. The potential improve-
ment in myocardial dysfunction may change
the treatment decision from heart transplant
to MV repair even when the EF is as low as
15%, as has been reported by Badwar [6].
2. NCCM is known to predispose to ventricular
arrhythmias especially perioperatively, which
can add to morbidity and mortality.
3. Thromboembolism, a known complication of
NCCM, needs to be considered and interven-
tions to prevent it initiated.
Limitations
This study contains a limited number of patients
with histopathological examinations.Conclusion
In what we believe is an under-diagnosed entity,
we described the mechanism of MR caused
by NCCM and its clinical, echocardiographic fea-
tures as well as intra operative and pathological
correlations.Appendix A. Supplementary data
Supplementary data associated with this article
can be found, in the online version, at http://
dx.doi.org/10.1016/j.jsha.2014.07.002.
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